PUBLISHER: DataM Intelligence | PRODUCT CODE: 1143396
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1143396
Contact us about how to customize the report with add-on data.
Isothermal Nucleic Acid Amplification Technology Market" size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 11.01% during the forecast period (2022-2029).
Isothermal nucleic acid amplification is a process that rapidly and efficiently accumulates nucleic acid sequences at a constant temperature. Nucleic acid amplification technologies are used in molecular biology and recombinant DNA technologies. These techniques are used as leading methods in detecting and analyzing a small number of nucleic acids. Isothermal nucleic acid amplification technology protocols have many advantages as it is swift and do not require thermocyclers.
The isothermal nucleic acid amplification technology (INAAT) market is growing due to the high adoption rate of INAAT over PCR, rising incidences of chronic diseases, growing geriatric population, and increasing demand for low-cost and effective diagnostics techniques.
The advantages and the future prospectus application of isothermal amplification propel the isothermal nucleic acid amplification technology global market growth.
The advantages and the future prospectus application of isothermal amplification fuel the global market growth. For instance, acknowledging the rising acceptance and application of isothermal methods for amplification of nucleic acids for easy and rapid detection of pathogenic microbes with accuracy, it is not presumptuous to imagine having an isothermal-based diagnostic not so far in the future. Some other methods are established as fresh innovations of already existing technologies, such as exponential amplification reaction (EXPAR), single chimeric primers isothermal amplification (SPIA), Isothermal and chimeric primer-initiated amplification of nucleic acids (ICAN), hairpin fluorescence probe-assisted isothermal amplification and beacon-assisted detection amplification. Furthermore, there seeming is a need for standardization of these methods since contrasting data exist about the performance of a few of these methods, which makes comparison difficult. The future will be to witness more compact hand-held diagnostic technologies That operate on isothermal principles and with accuracy and rapidity. Such advancement will positively change the current state of healthcare in developing countries since there is a huge problem while diagnosing diseases accurately. Therefore, to win the fight against the impact of diseases, especially in resource-constrained societies, there is a requirement for simple, rapid, yet sensitive diagnostic tests for clinical application, driving the global market growth.
The stringent regulatory policies and the high developmental cost restrain the global market growth.
The high cost and stringent regulatory policies for developing and producing isothermal nucleic acid amplification technology products hamper the global market growth.
The global isothermal nucleic acid amplification technology market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing analysis, Etc.
The loop-mediated isothermal amplification (LAMP) is assumed to command the global market throughout the forecast period (2022-2029).
Among these, the Loop-mediated Isothermal Amplification (LAMP) segment is growing at the fastest CAGR during the forecast period (2022-2029) as it is a widely used technique globally. The LAMP tests have been developed for various disease-causing agents due to their capability to amplify DNA and RNA. In this test, a set of four primers are used, two inner primers variousmers. Various software amplifies designing, such as primer explorer, LAMP designer, and other software. These loop primers bind to the nucleic acid template and further accelerate the reaction. LAMP technology is quick and sensitive, and amplification is so extensive that the magnesium pyrophosphate produced during the reaction can be seen by the eye, making LAMP well-suited for field diagnostics. LAMP technology is advantageous over PCR technology because the LAMP test is tolerant of PCR inhibitors, making it well-suited for direct sample analysis. Also, the complete procedure does not require a fixed temperature; these advantages make it useful for point-of-care (POC) diagnostics.
The North American region holds the largest market share of the global isothermal nucleic acid amplification technology market.
North America Dominated the global isothermal nucleic acid amplification technology (INAAT) market, accounting for the largest market share in 2021, owing to the rising incidences of chronic diseases, the high adoption rate of INAAT over conventional techniques, and technological advancement in isothermal nucleic acid amplification technology (INAAT) in this region. In the U.S., the number of infectious diseases is rising. Endemic diseases such as chronic hepatitis, HIV, and other sexually transmitted infections affect millions of individuals and widen health disparities. According to CDC, there were 7,163 new tuberculosis cases in the U.S. CDC estimates Salmonella bacteria cause about 1.35 million infections, 26,500 hospitalizations, and 420 deaths in the United States every year; in 2020, Wisconsin had 3,076 estimated cases of Lyme disease, and according to the National Meningitis Association around 600 - 1,000 people contract meningococcal disease in the U.S. each year. Hence, the demand for diagnostic technology increases, leading to continuous improvements in existing amplification products and new technologies.
The isothermal nucleic acid amplification second the (NAAT) the market is highly competitive with many players, including bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited, and Thermo Fisher Scientific. Through different strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, the key players contribute to the growth of the isothermal nucleic acid amplification technology (INAAT) market globally. For instance, on 19 May 2022, ThermoFisher partnered with LabShares to support the Greater Boston biotech ecosystem. Also, 0n 19 May 2022, bioMerieux acquired Specific Diagnostics.
Thermo Fisher Scientific
ThermoFisher is a U.S.-based company founded in 1956. It is the world leader in serving science with annual revenue of approx. $40 billion has industry-leading brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
The product portfolio of Thermo Fisher Scientific for isothermal nucleic acid amplification technology has Invitrogen SuperScript IV RT-LAMP Master Mix, Thermo Scientific Bsm DNA Polymerase, Large Fragment, Invitrogen*Colorimetric*ReadiLAMP Kit for SARS-CoV-2 and Ion Torrent Genexus Integrated Sequencer.
The global isothermal nucleic acid amplification technology market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.
LIST NOT EXHAUSTIVE